Clinical Edge Journal Scan

Clinical Edge Journal Scan

How useful is CRP as a marker for assessing disease activity in PsA?

• Read More

Clinical Edge Journal Scan

Rapid and sustained improvement in PsA with ustekinumab

• Read More

Clinical Edge Journal Scan

Isolated axial PsA and eventual development of peripheral disease

• Read More

Clinical Edge Journal Scan

Secukinumab delays disease flare in juvenile PsA

• Read More

Clinical Edge Journal Scan

Commentary: IL-Targeted Therapies and Nail Dystrophy in PsA, September 2022

Author:

Vinod Chandran, MBBS, MD, DM, PhD

• Read More

Clinical Edge Journal Scan

Fatigue impairs general health outcomes in PsA

• Read More

Clinical Edge Journal Scan

Elevated IL-23 levels associated with psychiatric disorders in PsA

• Read More

Clinical Edge Journal Scan

PsA remission depends on patient perception and is multidimensional

• Read More

Clinical Edge Journal Scan

Long-term safety and efficacy of risankizumab in PsA

• Read More

Clinical Edge Journal Scan

Robust and consistent improvement in HRQoL with guselkumab

• Read More